Form 8-K - Current report:
SEC Accession No. 0001104659-25-058532
Filing Date
2025-06-11
Accepted
2025-06-11 16:05:57
Documents
12
Period of Report
2025-06-10
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2517565d1_8k.htm   iXBRL 8-K 31705
  Complete submission text file 0001104659-25-058532.txt   197536

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA pvla-20250610.xsd EX-101.SCH 3020
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE pvla-20250610_lab.xml EX-101.LAB 34239
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pvla-20250610_pre.xml EX-101.PRE 22362
14 EXTRACTED XBRL INSTANCE DOCUMENT tm2517565d1_8k_htm.xml XML 3687
Mailing Address 125 STRAFFORD AVE SUITE 360 WAYNE PA 19087
Business Address 125 STRAFFORD AVE SUITE 360 WAYNE PA 19087 (484) 253-1461
PALVELLA THERAPEUTICS, INC. (Filer) CIK: 0001583648 (see all company filings)

EIN.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37471 | Film No.: 251039961
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)